RxDoctor Payments Data

Elisabeth Henry, PA

Medical · Tallahassee, FLNPI 1417324104

Payments from drug & device makers

$4,127in general payments, 2019–2025

Across 118 payments — averaging $34.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$734
  • Boston Scientific$642
  • Boehringer Ingelheim$530
  • Abbott$484
  • Pfizer$473
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$256
  • plus $1K from 12 others

What the payments were for

  • Food & beverage$4,127100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,127 in reported general payments places this provider in the 80th percentile of 2,031 medical providers in Florida.

See all medical providers in Florida

Medicare billing

Part B allowed, 2024
$77,430
Medicare patients
453
Services billed
1,147

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban295$207,648
XareltoRivaroxaban30$28,966
EntrestoSacubitril/Valsartan13$10,720
Dofetilide34$9,305
JardianceEmpagliflozin16$9,239
Diltiazem 24hr Er (Cd)Diltiazem Hcl63$2,747
Dabigatran EtexilateDabigatran Etexilate Mesylate14$2,625
Metoprolol Succinate140$2,084
Flecainide Acetate14$1,552
SotalolSotalol Hcl22$716
Carvedilol65$573
Amlodipine Besylate47$454
Cartia XtDiltiazem Hcl12$342
Losartan Potassium23$199
Amiodarone Hcl23$139

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$473$207,648295 claims
Johnson & JohnsonXarelto$180$28,96630 claims
NovartisEntresto$14$10,72013 claims
Boehringer IngelheimJardiance$530$9,23916 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,031 medical providers in Florida.

Other medical in Tallahassee

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →